Nishikawa M, Yamamoto M, Murakami T, Akatsu T, Kugai N, Nagata N
Third Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
J Bone Miner Res. 1998 Jun;13(6):986-95. doi: 10.1359/jbmr.1998.13.6.986.
The theory that bisphosphonates inhibit osteoclast formation through their effects on osteoblastic cells remains controversial. To confirm the inhibitory effect of bisphosphonates on osteoclast formation and gain some insights into the underlying mechanisms, we examined the effect of disodium dihydrogen (cycloheptylamino)-methylene-bisphosphonate monohydrate (YM175) on osteoclast-like multinucleated cell (OCL) formation in various mouse coculture systems. When different origins of osteoclast precursors (bone marrow, spleen, or nonspecific esterase-positive cells) were cocultured with the same supporting cells (calvarial osteoblasts), YM175 inhibited OCL formation similarly in all cultures. When the same osteoclast precursors (spleen cells) were cocultured with supporting cells of different origin, the results were variable. YM175 inhibited OCL formation almost completely in cocultures with calvarial osteoblasts or osteoblastic cell line KS4, while it did not, or only slightly, inhibit OCL formation in cocultures with stromal cell lines, ST2 or MC3T3-G2/PA6. Temporal addition of YM175 in cocultures of spleen cells with osteoblastic cells revealed that YM175 was effective when it was present at an early phase of the culture period. Consistent with this observation, YM175 in the presence of osteoblastic cells inhibited proliferation of preosteoclastic cells, but did not inhibit the fusion of mononuclear prefusion osteoclasts. In conclusion, the inhibitory effect of YM175 on OCL formation was confirmed in various murine coculture systems, but the effect was dependent on the types of bone-derived cells supporting osteoclastogenesis. The findings suggest that YM175 inhibits osteoclastogenesis by inhibiting the proliferation of osteoclast precursors through its action on supporting cells of osteoblast lineage rather than acting directly on osteoclast precursors.
双膦酸盐通过其对成骨细胞的作用来抑制破骨细胞形成的理论仍存在争议。为了证实双膦酸盐对破骨细胞形成的抑制作用并深入了解其潜在机制,我们研究了(环庚基氨基)亚甲基 - 双膦酸二氢二钠一水合物(YM175)在各种小鼠共培养系统中对破骨细胞样多核细胞(OCL)形成的影响。当不同来源的破骨细胞前体(骨髓、脾脏或非特异性酯酶阳性细胞)与相同的支持细胞(颅骨成骨细胞)共培养时,YM175在所有培养物中均类似地抑制OCL形成。当相同的破骨细胞前体(脾细胞)与不同来源的支持细胞共培养时,结果各不相同。YM175在与颅骨成骨细胞或成骨细胞系KS4共培养时几乎完全抑制OCL形成,而在与基质细胞系ST2或MC3T3 - G2/PA6共培养时则未抑制或仅轻微抑制OCL形成。在脾细胞与成骨细胞的共培养中适时添加YM175表明,YM175在培养期早期存在时是有效的。与此观察结果一致,在有成骨细胞存在的情况下,YM175抑制前破骨细胞的增殖,但不抑制单核前融合破骨细胞的融合。总之,在各种小鼠共培养系统中证实了YM175对OCL形成的抑制作用,但该作用取决于支持破骨细胞生成的骨源性细胞类型。这些发现表明,YM175通过作用于成骨细胞系的支持细胞来抑制破骨细胞前体的增殖,从而抑制破骨细胞生成,而不是直接作用于破骨细胞前体。